Biomea Fusion, Inc. (BMEA)
NASDAQ · Healthcare
Biomea Fusion, Inc. EBITDA 2020–2025
Biomea Fusion, Inc. annual/quarterly ebitda history and growth rate from 2020 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Biomea Fusion, Inc. ebitda for the quarter ending March 31, 2026 was -12.7 M, a 56.72% decrease year-over-year.
- Biomea Fusion, Inc. ebitda for the twelve months ending March 31, 2026 was -81.0 M.
- Biomea Fusion, Inc. annual ebitda for 2025 was -97.5 M, a 31.46% decrease from 2024.
- Biomea Fusion, Inc. annual ebitda for 2024 was -142.3 M, a 14.20% increase from 2023.
- Biomea Fusion, Inc. annual ebitda for 2023 was -124.6 M, a 50.25% increase from 2022.
- Biomea Fusion, Inc. annual ebitda for 2022 was -82.9 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Biomea Fusion, Inc. EBITDA — FAQ
Biomea Fusion, Inc. (BMEA) ebitda over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BMEA's ebitda history?
The chart and table above show Biomea Fusion, Inc.'s ebitda by year and by quarter, including the growth rate.